Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-25-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 31, 2025 |
| Document Date | Dec 29, 2025 |
| Document | View SEC Filing |
Transactions
4
Total Shares
135,000
Total Value
$2,294,254.84
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D & CMO | Common Stock | โ | Dec 29, 2025 | Exercise/Conversion | 45,000 | $10.42 | $468,900.00 | 45,000 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Dec 29, 2025 | Sale | 27,800 | $40.34 | $1,121,424.20 | 17,200 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Dec 29, 2025 | Sale | 17,200 | $40.93 | $703,930.64 | 0 | Direct | โ | View Details | |
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Dec 29, 2025 | Exercise/Conversion | 45,000 | $0.00 | $0.00 | 342,407 | Direct | โ | View Details |